No abstract available
MeSH terms
-
Antineoplastic Agents / therapeutic use
-
Breast Neoplasms / drug therapy*
-
Chemotherapy, Adjuvant
-
Clinical Trials as Topic*
-
Disease-Free Survival
-
Female
-
Follow-Up Studies
-
Humans
-
Middle Aged
-
Ovary / drug effects
-
Postmenopause
-
Premenopause
-
Randomized Controlled Trials as Topic
-
Survival Rate
-
Tamoxifen / administration & dosage
-
Tamoxifen / therapeutic use*
-
United Kingdom
Substances
-
Antineoplastic Agents
-
Tamoxifen